These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Intravenous infusion of auto serum-expanded autologous mesenchymal stem cells in spinal cord injury patients: 13 case series. Honmou O; Yamashita T; Morita T; Oshigiri T; Hirota R; Iyama S; Kato J; Sasaki Y; Ishiai S; Ito YM; Namioka A; Namioka T; Nakazaki M; Kataoka-Sasaki Y; Onodera R; Oka S; Sasaki M; Waxman SG; Kocsis JD Clin Neurol Neurosurg; 2021 Apr; 203():106565. PubMed ID: 33667953 [TBL] [Abstract][Full Text] [Related]
3. Autologous intravenous bone marrow mononuclear cell therapy for patients with subacute ischaemic stroke: a pilot study. Prasad K; Mohanty S; Bhatia R; Srivastava MV; Garg A; Srivastava A; Goyal V; Tripathi M; Kumar A; Bal C; Vij A; Mishra NK Indian J Med Res; 2012 Aug; 136(2):221-8. PubMed ID: 22960888 [TBL] [Abstract][Full Text] [Related]
4. The effects of intravenous infusion of autologous mesenchymal stromal cells in patients with subacute middle cerebral artery infarct: a phase 2 randomized controlled trial on safety, tolerability and efficacy. Law ZK; Tan HJ; Chin SP; Wong CY; Wan Yahya WNN; Muda AS; Zakaria R; Ariff MI; Ismail NA; Cheong SK; S Abdul Wahid SF; Mohamed Ibrahim N Cytotherapy; 2021 Sep; 23(9):833-840. PubMed ID: 33992536 [TBL] [Abstract][Full Text] [Related]
5. Intravenous transplantation of mesenchymal stem cells preconditioned with early phase stroke serum: current evidence and study protocol for a randomized trial. Kim SJ; Moon GJ; Chang WH; Kim YH; Bang OY; Trials; 2013 Oct; 14():317. PubMed ID: 24083670 [TBL] [Abstract][Full Text] [Related]
6. Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open-label phase 2a proof-of-concept study. Connick P; Kolappan M; Crawley C; Webber DJ; Patani R; Michell AW; Du MQ; Luan SL; Altmann DR; Thompson AJ; Compston A; Scott MA; Miller DH; Chandran S Lancet Neurol; 2012 Feb; 11(2):150-6. PubMed ID: 22236384 [TBL] [Abstract][Full Text] [Related]
7. Intrathecal Injection of Allogenic Bone Marrow-Derived Mesenchymal Stromal Cells in Treatment of Patients with Severe Ischemic Stroke: Study Protocol for a Randomized Controlled Observer-Blinded Trial. Deng L; Peng Q; Wang H; Pan J; Zhou Y; Pan K; Li J; Wu Y; Wang Y Transl Stroke Res; 2019 Apr; 10(2):170-177. PubMed ID: 29796934 [TBL] [Abstract][Full Text] [Related]
8. A Phase 2 Randomized, Sham-Controlled Trial of Internal Carotid Artery Infusion of Autologous Bone Marrow-Derived ALD-401 Cells in Patients With Recent Stable Ischemic Stroke (RECOVER-Stroke). Savitz SI; Yavagal D; Rappard G; Likosky W; Rutledge N; Graffagnino C; Alderazi Y; Elder JA; Chen PR; Budzik RF; Tarrel R; Huang DY; Hinson JM Circulation; 2019 Jan; 139(2):192-205. PubMed ID: 30586746 [TBL] [Abstract][Full Text] [Related]
9. Feasibility of delivering mesenchymal stem cells via catheter to the proximal end of the lesion artery in patients with stroke in the territory of the middle cerebral artery. Jiang Y; Zhu W; Zhu J; Wu L; Xu G; Liu X Cell Transplant; 2013; 22(12):2291-8. PubMed ID: 23127560 [TBL] [Abstract][Full Text] [Related]
11. [Phase III clinical trial using autologous mesenchymal stem cells for stroke patients]. Honmou O Nihon Rinsho; 2016 Apr; 74(4):649-54. PubMed ID: 27333754 [TBL] [Abstract][Full Text] [Related]
12. Phase I/II Study of Safety and Preliminary Efficacy of Intravenous Allogeneic Mesenchymal Stem Cells in Chronic Stroke. Levy ML; Crawford JR; Dib N; Verkh L; Tankovich N; Cramer SC Stroke; 2019 Oct; 50(10):2835-2841. PubMed ID: 31495331 [TBL] [Abstract][Full Text] [Related]
13. Reparative therapy for acute ischemic stroke with allogeneic mesenchymal stem cells from adipose tissue: a safety assessment: a phase II randomized, double-blind, placebo-controlled, single-center, pilot clinical trial. Díez-Tejedor E; Gutiérrez-Fernández M; Martínez-Sánchez P; Rodríguez-Frutos B; Ruiz-Ares G; Lara ML; Gimeno BF J Stroke Cerebrovasc Dis; 2014; 23(10):2694-2700. PubMed ID: 25304723 [TBL] [Abstract][Full Text] [Related]
14. Autologous mesenchymal stem cell transplantation in stroke patients. Bang OY; Lee JS; Lee PH; Lee G Ann Neurol; 2005 Jun; 57(6):874-82. PubMed ID: 15929052 [TBL] [Abstract][Full Text] [Related]
15. Intra-discal injection of autologous, hypoxic cultured bone marrow-derived mesenchymal stem cells in five patients with chronic lower back pain: a long-term safety and feasibility study. Elabd C; Centeno CJ; Schultz JR; Lutz G; Ichim T; Silva FJ J Transl Med; 2016 Sep; 14(1):253. PubMed ID: 27585696 [TBL] [Abstract][Full Text] [Related]
16. Intracerebral transplantation of MRI-trackable autologous bone marrow stromal cells for patients with subacute ischemic stroke. Kawabori M; Kuroda S; Shichinohe H; Kahata K; Shiratori S; Ikeda S; Harada T; Hirata K; Tha KK; Aragaki M; Terasaka S; Ito YM; Nishimoto N; Ohnishi S; Yabe I; Kudo K; Houkin K; Fujimura M Med; 2024 May; 5(5):432-444.e4. PubMed ID: 38547868 [TBL] [Abstract][Full Text] [Related]
17. A two-year follow-up study of cotransplantation with neural stem/progenitor cells and mesenchymal stromal cells in ischemic stroke patients. Qiao LY; Huang FJ; Zhao M; Xie JH; Shi J; Wang J; Lin XZ; Zuo H; Wang YL; Geng TC Cell Transplant; 2014; 23 Suppl 1():S65-72. PubMed ID: 25333752 [TBL] [Abstract][Full Text] [Related]
18. Treatment of lumbar degenerative disc disease-associated radicular pain with culture-expanded autologous mesenchymal stem cells: a pilot study on safety and efficacy. Centeno C; Markle J; Dodson E; Stemper I; Williams CJ; Hyzy M; Ichim T; Freeman M J Transl Med; 2017 Sep; 15(1):197. PubMed ID: 28938891 [TBL] [Abstract][Full Text] [Related]